Adaptyv Bio operates a fully automated protein foundry that enables AI-generated protein design validation in just 3 weeks. The company bridges the gap between computational protein design and experimental validation using advanced robotics, microfluidics and synthetic biology. Founded by EPFL engineers and backed by Y Combinator, they've raised $11.2 million to scale their next-generation platform. They serve the fastest-moving protein design teams globally and are building the world's largest protein design database.